Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies.

Cheah PL, Looi LM, Teoh KH, Mun KS, Nazarina AR.

Asian Pac J Cancer Prev. 2012;13(2):469-72.

4.

p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.

Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B.

Pathology. 2005 Apr;37(2):112-24.

PMID:
16028838
5.
6.

Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.

Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F.

Acta Cytol. 2012;56(5):506-14. doi: 10.1159/000338979. Epub 2012 Sep 27.

PMID:
23075891
7.
8.

Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.

Saqi A, Pasha TL, McGrath CM, Yu GH, Zhang P, Gupta P.

Diagn Cytopathol. 2002 Dec;27(6):365-70.

PMID:
12451568
10.

Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.

Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.

Coll Antropol. 2010 Mar;34(1):19-24.

PMID:
20432728
11.
12.

Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.

Razmpoosh M, Sansregret A, Oligny LL, Patey N, Dormoy-Raclet V, Ducruet T, Bouron-Dal Soglio D.

Am J Clin Pathol. 2014 Jul;142(1):104-10. doi: 10.1309/AJCPBX74QXCPXIKK.

13.
14.

Immunocytochemical staining of p16(ink4a) protein as an adjunct test in equivocal liquid-based cytology.

Shin EK, Lee SR, Kim MK, Kang EJ, Ju W, Lee SN, Han WS, Kim SC.

Diagn Cytopathol. 2008 May;36(5):311-6. doi: 10.1002/dc.20786.

PMID:
18418881
15.

Immunocytochemistry of p16INK4a in liquid-based cervicovaginal specimens with modified Papanicolaou counterstaining.

Negri G, Moretto G, Menia E, Vittadello F, Kasal A, Mian C, Egarter-Vigl E.

J Clin Pathol. 2006 Aug;59(8):827-30. Epub 2006 Feb 7.

16.

Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.

Yildiz IZ, Usubütün A, Firat P, Ayhan A, Küçükali T.

Pathol Res Pract. 2007;203(6):445-9. Epub 2007 May 31. Review.

PMID:
17543474
17.

Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.

Howitt BE, Nucci MR, Drapkin R, Crum CP, Hirsch MS.

Am J Surg Pathol. 2013 Jan;37(1):89-97. doi: 10.1097/PAS.0b013e3182753f5a.

PMID:
23211296
19.

Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.

Koo YJ, Hahn HS, Lee IH, Lim KT, Lee KH, Kim HS, Kim TJ, Chun YK, Kim HS, Hong SR.

Virchows Arch. 2013 Nov;463(5):689-96. doi: 10.1007/s00428-013-1483-4. Epub 2013 Oct 1.

PMID:
24081504
20.

p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.

Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ.

J Clin Pathol. 2003 Jan;56(1):56-63.

Items per page

Supplemental Content

Write to the Help Desk